{"id":"https://openalex.org/W4284683032","doi":"https://doi.org/10.1097/cji.0000000000000427","title":"The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models","display_name":"The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models","publication_year":2022,"publication_date":"2022-07-05","ids":{"openalex":"https://openalex.org/W4284683032","doi":"https://doi.org/10.1097/cji.0000000000000427","pmid":"https://pubmed.ncbi.nlm.nih.gov/35791438"},"language":"en","primary_location":{"id":"doi:10.1097/cji.0000000000000427","doi":"https://doi.org/10.1097/cji.0000000000000427","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cji.0000000000000427","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108401374","display_name":"Liliane Robillard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Liliane Robillard","raw_affiliation_strings":["Departments of Translational Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Translational Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079934230","display_name":"Mingxiang Liao","orcid":"https://orcid.org/0000-0003-1853-1419","observed_orcids":["https://orcid.org/0000-0003-1853-1419"]},"institutions":[{"id":"https://openalex.org/I4210151488","display_name":"Clovis Oncology (United States)","ror":"https://ror.org/04ps4d441","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151488"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mingxiang Liao","raw_affiliation_strings":["Clinical Pharmacology, Clovis Oncology Inc., Boulder, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Clovis Oncology Inc., Boulder, CO","institution_ids":["https://openalex.org/I4210151488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110198165","display_name":"Minh Nguyen","orcid":"https://orcid.org/0000-0002-9159-147X","observed_orcids":["https://orcid.org/0000-0002-9159-147X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Minh Nguyen","raw_affiliation_strings":["Departments of Translational Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Translational Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110849850","display_name":"Thomas C. Harding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Thomas C. Harding","raw_affiliation_strings":["Departments of Translational Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Translational Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103133276","display_name":"Andrew D. Simmons","orcid":"https://orcid.org/0000-0001-6075-0549","observed_orcids":["https://orcid.org/0000-0001-6075-0549"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Andrew D. Simmons","raw_affiliation_strings":["Departments of Translational Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Translational Medicine","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108748729","display_name":"Rachel L. Dusek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rachel L. Dusek","raw_affiliation_strings":["Departments of Translational Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Translational Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103133276","https://openalex.org/A5108401374","https://openalex.org/A5108748729","https://openalex.org/A5110198165","https://openalex.org/A5110849850"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5761,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.64276674,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":"45","issue":"8","first_page":"335","last_page":"348"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.859000027179718},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.8999999761581421},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.8220000267028809},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.9559999704360962},{"id":"https://openalex.org/keywords/gitr","display_name":"GITR","score":0.9900000095367432},{"id":"https://openalex.org/keywords/inducible-t-cell-costimulator","display_name":"ICOS","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ox40","display_name":"OX40","score":1.0},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9599999785423279},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9089999794960022},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.6600000262260437},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.6869999766349792},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.6610000133514404},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.7549999952316284},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.7179999947547913},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6454392671585083},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.622918426990509},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5771127939224243},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5513541102409363},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.524857759475708},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.41413623094558716},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38975247740745544},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35702112317085266},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3182719945907593},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10327062010765076},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cji.0000000000000427","doi":"https://doi.org/10.1097/cji.0000000000000427","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cji.0000000000000427","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:35791438","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35791438","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy (Hagerstown, Md. : 1997)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":74,"referenced_works":["https://openalex.org/W1518184777","https://openalex.org/W1562104909","https://openalex.org/W1930224602","https://openalex.org/W1959403697","https://openalex.org/W1997533142","https://openalex.org/W2032410318","https://openalex.org/W2074898491","https://openalex.org/W2087255713","https://openalex.org/W2088571368","https://openalex.org/W2100374586","https://openalex.org/W2100453921","https://openalex.org/W2102979753","https://openalex.org/W2103079055","https://openalex.org/W2106747061","https://openalex.org/W2106932520","https://openalex.org/W2115736737","https://openalex.org/W2117971287","https://openalex.org/W2121820529","https://openalex.org/W2140069170","https://openalex.org/W2149319722","https://openalex.org/W2154516141","https://openalex.org/W2156906256","https://openalex.org/W2159999569","https://openalex.org/W2161730969","https://openalex.org/W2275872217","https://openalex.org/W2329974159","https://openalex.org/W2470333723","https://openalex.org/W2544675721","https://openalex.org/W2561690133","https://openalex.org/W2565014445","https://openalex.org/W2595314544","https://openalex.org/W2605792367","https://openalex.org/W2612419201","https://openalex.org/W2728594144","https://openalex.org/W2747776687","https://openalex.org/W2766738495","https://openalex.org/W2779155953","https://openalex.org/W2791328450","https://openalex.org/W2791667426","https://openalex.org/W2793442783","https://openalex.org/W2794419219","https://openalex.org/W2794836336","https://openalex.org/W2801571624","https://openalex.org/W2804661897","https://openalex.org/W2810896552","https://openalex.org/W2892371440","https://openalex.org/W2898915459","https://openalex.org/W2901757914","https://openalex.org/W2911812451","https://openalex.org/W2913745075","https://openalex.org/W2917680953","https://openalex.org/W2954312219","https://openalex.org/W2954523357","https://openalex.org/W2955269932","https://openalex.org/W2965242861","https://openalex.org/W2970410478","https://openalex.org/W2981115842","https://openalex.org/W2984962695","https://openalex.org/W2989029645","https://openalex.org/W2997652717","https://openalex.org/W3008414152","https://openalex.org/W3011919019","https://openalex.org/W3025022288","https://openalex.org/W3030262234","https://openalex.org/W3045387409","https://openalex.org/W3083071627","https://openalex.org/W3089327224","https://openalex.org/W3091948129","https://openalex.org/W3092621559","https://openalex.org/W3110414417","https://openalex.org/W4205626317","https://openalex.org/W4255590017","https://openalex.org/W4297769674","https://openalex.org/W7074101881"],"related_works":["https://openalex.org/W2954312219","https://openalex.org/W3083071627","https://openalex.org/W3089327224","https://openalex.org/W3088219178","https://openalex.org/W2917680953","https://openalex.org/W4407849807","https://openalex.org/W2793442783","https://openalex.org/W2398707058","https://openalex.org/W4388476258","https://openalex.org/W4383224437"],"abstract_inverted_index":{"Lucitanib":[0,31,121],"is":[1,28],"a":[2,80],"multi-tyrosine":[3],"kinase":[4],"inhibitor":[5],"whose":[6],"targets":[7],"are":[8,22],"associated":[9,184],"with":[10,113,123,159,185,200,207,223,254,268],"angiogenesis":[11],"and":[12,16,44,49,53,78,92,165,195,217,245,252],"other":[13],"key":[14],"cancer":[15],"immune":[17,94,138,186,246,269],"pathways.":[18],"Its":[19],"antiangiogenic":[20],"properties":[21],"understood,":[23],"but":[24],"lucitanib's":[25,86],"immunomodulatory":[26],"activity":[27,34,111,144,187],"heretofore":[29],"unknown.":[30],"exhibited":[32,108],"such":[33],"in":[35,57,117,149,182,192],"vivo,":[36],"increasing":[37],"CD3":[38],"+":[39,42,46,63,82,163,168,212],",":[40,43],"CD8":[41,62,81,211],"CD4":[45],"T":[47,64,178],"cells":[48,52,56,65],"decreasing":[50],"dendritic":[51],"monocyte-derived":[54],"suppressor":[55],"mouse":[58],"spleens.":[59],"Depletion":[60],"of":[61,76,85,90,125,176,248,265],"from":[66],"syngeneic":[67],"MC38":[68,193],"colon":[69],"tumor-bearing":[70],"mice":[71],"reduced":[72,161],"the":[73,146,174,249,262],"antitumor":[74,110,143,216,258],"efficacy":[75],"lucitanib":[77,91,191,241,266],"revealed":[79],"T-cell-dependent":[83],"component":[84],"activity.":[87],"The":[88],"combination":[89,199],"costimulatory":[93],"pathway":[95,270],"agonists":[96],"targeting":[97],"4-1BB,":[98],"glucocorticoid-induced":[99],"TNFR":[100],"(GITR),":[101],"inducible":[102],"T-cell":[103,213],"co-stimulator":[104],"(ICOS),":[105],"or":[106,131,157,205,221],"OX40":[107],"enhanced":[109,142],"compared":[112],"each":[114],"single":[115,147],"agent":[116],"immunocompetent":[118],"tumor":[119,250],"models.":[120,151],"combined":[122,158,206,222,267],"blockade":[124],"cytotoxic":[126],"T-lymphocyte-associated":[127],"protein":[128],"4":[129],"(CTLA-4)":[130],"programmed":[132],"cell":[133],"death":[134],"protein-1":[135],"(PD-1)":[136],"coinhibitory":[137],"pathways":[139,183],"also":[140,172],"showed":[141],"over":[145],"agents":[148],"multiple":[150],"In":[152],"CT26":[153],"tumors,":[154],"lucitanib,":[155,203],"alone":[156,204,220],"anti-PD-1,":[160,208,224],"CD31":[162],"vessels":[164],"depleted":[166],"F4/80":[167],"macrophages.":[169],"Combination":[170],"treatment":[171],"increased":[173,209],"number":[175],"intratumoral":[177,210],"cells.":[179],"Gene":[180],"expression":[181],"was":[188,225],"upregulated":[189],"by":[190,198,228],"tumors":[194],"further":[196],"potentiated":[197],"anti-PD-1.":[201],"Accordingly,":[202],"abundance.":[214],"Lucitanib's":[215],"pharmacodynamic":[218],"activity,":[219],"not":[226],"recapitulated":[227],"specific":[229],"vascular":[230,244],"endothelial":[231],"growth":[232],"factor":[233],"receptor-2":[234],"(VEGFR2)":[235],"inhibition.":[236],"These":[237],"data":[238],"indicate":[239],"that":[240],"can":[242],"modulate":[243],"components":[247],"microenvironment":[251],"cooperate":[253],"immunotherapy":[255],"to":[256,272],"enhance":[257],"efficacy.":[259],"They":[260],"support":[261],"clinical":[263],"development":[264],"modulators":[271],"treat":[273],"cancer.":[274]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-07-08T00:00:00"}